BioWorld

March 18, 2002

NIH Releases Research Agenda For Program On Bioterrorism

WASHINGTON - The National Institutes of Health expects to spend portions of its proposed $1.7 billion bioterrorism budget testing vaccines for threats such as anthrax, smallpox and botulism. (BioWorld Today) Read More

ChemGenex Using Chemical Genomics To Move Drugs Along

Viral Culpability In Autoimmunity Confirmed In Transgenic Diabetic Mice Aided By Antiviral Interferon

BioWorld’s Annual Report Published

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Dec. 19, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 19, 2025.

Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

HIV research is close to a cure but far from ending the pandemic

BioWorld

Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...

Apollo’s APL-4098 shows potent antileukemic effects

BioWorld Science

Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.

Illustration of brain with electrical activity background

ABS-1230 controls seizures in KCNT1-driven severe epilepsy

BioWorld Science

Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...